Text Size
16528 studies found for:    updated in the last 60 days

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Positron Emission Tomography (PET) to Study Brain Signaling
Condition: Healthy
Intervention:
2 Completed Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
Condition: Non-melanomatous Skin Cancer
Interventions: Drug: imiquimod;   Procedure: conventional surgery
3 Completed
Has Results 		BAY43-9006 - Phase II in Advanced Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
4 Completed
Has Results 		Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: Insulin glargine;   Drug: Metformin
5 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis, Knee
Intervention: Drug: GW406381
6 Active, not recruiting Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: OSI-774 (Tarceva)
7 Active, not recruiting
Has Results 		Therapy for Pediatric Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: 12 Week Stanford V Chemotherapy;   Drug: 4 cycles of VAMP chemotherapy;   Drug: 2 alternating cycles of VAMP/COP chemotherapy;   Drug: 3 alternating cycles of VAMP/COP chemotherapy
8 Completed The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis
Intervention: Drug: Ampligen
9 Completed Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Drug: gemcitabine hydrochloride
10 Terminated Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung;   Metastases
Intervention: Drug: zoledronic acid
11 Completed Body Heat Content and Dissipation in Obese and Normal Weight Adults
Condition: Obesity
Intervention:
12 Active, not recruiting Vaccine Therapy in Treating Patients Who Are Being Considered For a Solid Organ Transplant and Are at Risk For Post-Transplant Lymphoproliferative Disorder
Condition: Lymphoproliferative Disorder
Intervention: Biological: autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine
13 Completed A Case-Referent Study of Brain Tumors in Adults
Condition: Brain Tumors
Intervention:
14 Completed Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
Conditions: Chromosomal Aberrations;   Cosmic Radiation
Intervention:
15 Terminated AFP464 in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: AFP464;   Other: laboratory biomarker analysis;   Other: pharmacological study
16 Completed Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Condition: Prostate Cancer
Intervention: Drug: dutasteride
17 Recruiting Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
18 Completed
Has Results 		Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
Condition: Anxiety
Interventions: Behavioral: Anxiety Self-Management, Patient preferred relaxing music;   Behavioral: Control 1: Noise-cancelling headphones;   Behavioral: Control 2: Standard of Care
19 Completed
Has Results 		A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Avandamet 6 mg/1500 mg (ttd);   Drug: Avandamet 4 mg/1000 mg (ttd);   Drug: Avandamet 2 mg/500 mg (ttd);   Drug: Avandamet 8 mg/ 2000 mg (ttd);   Drug: Metformin 500 mg (ttd);   Drug: Metformin 1000 mg (ttd);   Drug: Metformin 1500 mg (ttd);   Drug: Metformin 2000 mg (ttd)
20 Completed Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
Conditions: Growth Failure;   X-linked Severe Combined Immunodeficiency (XSCID);   Growth Hormone Resistence
Interventions: Drug: Increlex;   Procedure: Arginine Provocation Test;   Procedure: Clonidine Provocation Test;   Procedure: IGF-1 Generation Test;   Drug: IVIG;   Procedure: Haplo-Identical Bone Marrow Transplant
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years